WASHINGTON, Aug. 22 -- Rep. John Moolenaar, R-Michigan, chairman of the House Select Committee on the Strategic Competition Between the U.S. and the Chinese Communist Party, issued the following news release:

* * *

Moolenaar to FDA: "Chinese Clinical Data Poses Real Risks for Patients"

Chairman John Moolenaar of the Select Committee on China (R-MI) and Congressman Ben Cline (R-VA) have sent a letter to Acting Commissioner Kyle Diamantas of the Fo . . .

Click here for more information about our products